Brown University at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Brown University takes part in 3 sessions at CTAD 2026 in Boston. Its program spans ARIA risk during anti-amyloid therapy, amyloid PET positivity across racial and ethnic groups and synaptic proteins as trial endpoints.

Organization	CTAD 2026 Attendance
Brown University Providence, Rhode Island
	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Blood Pressure and Amyloid-Related Imaging Abnormalities During Anti-Amyloid Therapy: An Exploratory Meta-Analysis (P137) Anti-amyloid and anti-tau therapies Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Age-Specific Probabilities of Amyloid-PET Positivity Across Racial and Ethnic Groups: Results from HABS-HD (P159) PET and MRI imaging · Prevention and early disease Poster Wed Nov 18 7:15am–5:30pm From Bench to Bedside: Presynaptic Complexins as Synaptic Endpoints for Alzheimer’s Disease Trials (P251) Blood and CSF biomarkers

Organization

CTAD 2026 Attendance

Brown University

Providence, Rhode Island

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Blood Pressure and Amyloid-Related Imaging Abnormalities During Anti-Amyloid Therapy: An Exploratory Meta-Analysis (P137)

Anti-amyloid and anti-tau therapies

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Age-Specific Probabilities of Amyloid-PET Positivity Across Racial and Ethnic Groups: Results from HABS-HD (P159)

PET and MRI imaging · Prevention and early disease

Poster

Wed Nov 18
7:15am–5:30pm

From Bench to Bedside: Presynaptic Complexins as Synaptic Endpoints for Alzheimer’s Disease Trials (P251)

Blood and CSF biomarkers

Instantly find 20 buyers from Brown University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction